| Clinical and radiographic spectrum of pathologically confirmed tumefactive multiple sclerosis CF Lucchinetti, RH Gavrilova, I Metz, JE Parisi, BW Scheithauer, ... Brain 131 (7), 1759-1775, 2008 | 533 | 2008 |
| Behçet's disease: diagnostic and prognostic aspects of neurological involvement A Siva, OH Kantarci, S Saip, A Altintas, V Hamuryudan, C Islak, N Koçer, ... Journal of neurology 248, 95-103, 2001 | 434 | 2001 |
| Conversion from clinically isolated syndrome to multiple sclerosis: a large multicentre study J Kuhle, G Disanto, R Dobson, R Adiutori, L Bianchi, J Topping, ... Multiple Sclerosis Journal 21 (8), 1013-1024, 2015 | 377 | 2015 |
| Behçet's syndrome and the nervous system A Siva, A Altintas, S Saip Current opinion in neurology 17 (3), 347-357, 2004 | 269 | 2004 |
| Multicentre comparison of a diagnostic assay: aquaporin-4 antibodies in neuromyelitis optica P Waters, M Reindl, A Saiz, K Schanda, F Tuller, V Kral, P Nytrova, ... Journal of Neurology, Neurosurgery & Psychiatry 87 (9), 1005-1015, 2016 | 256 | 2016 |
| Fatigue and sleep disturbance in multiple sclerosis H Kaynak, A Altintaş, D Kaynak, Ö Uyanik, S Saip, J Ağaoğlu, G Önder, ... European Journal of Neurology 13 (12), 1333-1339, 2006 | 232 | 2006 |
| Baló's concentric sclerosis: clinical and radiologic features of five cases E Karaarslan, A Altintas, U Senol, N Yeni, A Dincer, C Bayindir, ... American journal of neuroradiology 22 (7), 1362-1367, 2001 | 184 | 2001 |
| Clinical and radiological characteristics of tumefactive demyelinating lesions: follow-up study A Altintas, B Petek, N Isik, M Terzi, F Bolukbasi, M Tavsanli, S Saip, C Boz, ... Multiple Sclerosis Journal 18 (10), 1448-1453, 2012 | 159 | 2012 |
| Consensus definitions and application guidelines for control groups in cerebrospinal fluid biomarker studies in multiple sclerosis C Teunissen, T Menge, A Altintas, JC Álvarez-Cermeño, A Bertolotto, ... Multiple Sclerosis Journal 19 (13), 1802-1809, 2013 | 156 | 2013 |
| Multiple sclerosis risk in radiologically uncovered asymptomatic possible inflammatory-demyelinating disease A Siva, S Saip, A Altintas, A Jacob, BM Keegan, OH Kantarci Multiple Sclerosis Journal 15 (8), 918-927, 2009 | 126 | 2009 |
| Headache in Behçet's syndrome S Saip, A Siva, A Altintas, A Kiyat, E Seyahi, V Hamuryudan, H Yazici Headache: The Journal of Head and Face Pain 45 (7), 911-919, 2005 | 120 | 2005 |
| Migraine in cervical artery dissection and ischemic stroke patients TM Metso, T Tatlisumak, S Debette, J Dallongeville, ST Engelter, PA Lyrer, ... Neurology 78 (16), 1221-1228, 2012 | 117 | 2012 |
| Characterization of neuromyelitis optica and neuromyelitis optica spectrum disorder patients with a late onset N Collongues, R Marignier, A Jacob, MI Leite, A Siva, F Paul, H Zephir, ... Multiple Sclerosis Journal 20 (8), 1086-1094, 2014 | 114 | 2014 |
| Neurofilament ELISA validation A Petzold, A Altintas, L Andreoni, A Bartos, A Berthele, MA Blankenstein, ... Journal of immunological methods 352 (1-2), 23-31, 2010 | 111 | 2010 |
| Familial occurrence and heritable connective tissue disorders in cervical artery dissection S Debette, B Goeggel Simonetti, S Schilling, JJ Martin, M Kloss, ... Neurology 83 (22), 2023-2031, 2014 | 101 | 2014 |
| Association of APOE polymorphisms with disease severity in MS is limited to women OH Kantarci, DD Hebrink, SJ Achenbach, SJ Pittock, A Altintas, ... Neurology 62 (5), 811-814, 2004 | 94 | 2004 |
| Treatment of MOG antibody associated disorders: results of an international survey DH Whittam, V Karthikeayan, E Gibbons, R Kneen, S Chandratre, ... Journal of neurology 267, 3565-3577, 2020 | 93 | 2020 |
| CADISP-Genetics: An International Project Searching for Genetic Risk Factors of Cervical Artery Dissections S Debette, TM Metso, A Pezzini, ST Engelter, D Leys, P Lyrer, AJ Metso, ... International Journal of Stroke 4 (3), 224-230, 2009 | 85 | 2009 |
| Kappa free light chains is a valid tool in the diagnostics of MS: A large multicenter study CE Leurs, HAM Twaalfhoven, BI Lissenberg-Witte, V Van Pesch, ... Multiple Sclerosis Journal 26 (8), 912-923, 2020 | 84 | 2020 |
| Natalizumab plus interferon beta-1a reduces lesion formation in relapsing multiple sclerosis EW Radue, WH Stuart, PA Calabresi, C Confavreux, SL Galetta, ... Journal of the neurological sciences 292 (1-2), 28-35, 2010 | 84 | 2010 |
